FARMINGDALE, N.Y.--(BUSINESS WIRE)--Misonix, Inc. (NASDAQ: MSON), a developer of ultrasonic medical device technology for the treatment of cancer and other chronic health conditions, today announced that Dr. W. Paul Constantine has resigned his position as Sr. Vice President of Sales, Marketing and New Product Development effective January 15, 2007 to take a leadership role with a portfolio company of venture capital firm Kleiner, Perkins, Caufield & Byers.
